Delivery Order SPE2DB24D1205-SPE2DB25FCXVY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on September 11, 2025, with a ceiling value of $3,388.86. This firm fixed-price delivery order, which has no set-aside designation, represents a competitively awarded procurement supporting federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $4,618.27 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Valtoco 10 mg nasal sprays. This firm fixed price, non-set-aside contract was delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. The delivery order represents a standard pharmaceutical procurement mechanism under the federal medical supply chain. This award is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $2,551.20 and ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $1,166.08. This firm fixed price delivery order represents a non-competitive set-aside award and is scheduled for completion by July 31, 2025. The award was performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,397.66 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price contract, with no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $1,479.55 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 29, 2025. This firm fixed-price contract, awarded on August 28, 2025, represents a non-set-aside competitive procurement. The contract is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on September 9, 2025, with a contract ceiling value of $2,257.08. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 10, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $2,423.27 to supply Valtoco 5 mg nasal sprays, with a completion deadline of June 2, 2025. This competitively awarded, non-set-aside contract uses firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,259.24 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of September 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a direct delivery order under the company's existing indefinite delivery vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $2,613.58 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays, with a completion deadline of September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXVYDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,688.44 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Valtoco 10 mg nasal sprays, with an ultimate completion date of June 20, 2025. The contract employs firm fixed pricing with no set-aside designation, reflecting a competitive award to this major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The delivery order structure demonstrates the operational flexibility of the IDC, allowing DLA to procure specific pharmaceutical commodities as needed to support federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 6/18/25 |